Related Experiment Video
Updated: May 22, 2026
07:51
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Educational Leadership for Sustainable Capacity Building Towards Enhancing Interdisciplinary Collaboration in
Peter Chinedu Agu1,2, Miracle Uzochukwu Okafor3,4, Chioma Blessing Momah5
1Key Laboratory of Luminescence Analysis and Molecular Sensing (Ministry of Education), College of Pharmaceutical Sciences and Chinese Medicine, Southwest University, Chongqing, China.
Summary
Educational leadership is key to strengthening interdisciplinary collaboration in pharmaceutical sciences, including network pharmacology and computer-aided drug design (CADD). This fosters sustainable capacity growth and innovation.
Area of Science:
- Pharmaceutical Sciences
- Network Pharmacology
- Computer-Aided Drug Design (CADD)
Background:
- Multidisciplinary collaboration is vital for sustainable growth in pharmaceutical sciences.
- Interdisciplinary research methods and technology integration require effective leadership.
- Existing studies show a trend towards collaboration but often lack leadership integration.
Purpose of the Study:
- To investigate how educational leadership can enhance interdisciplinary research in pharmaceutical sciences.
- To identify strategies for fostering sustainable technology integration and collaboration.
- To analyze the current landscape of research on network pharmacology and CADD collaboration.
Main Methods:
- Systematic literature search conducted in Scopus and Web of Science (WoS) databases.
- Search terms included 'network pharmacology,' 'interdisciplinary collaboration,' 'pharmaceutical sciences,' 'computer-aided drug design,' and 'educational leadership.'
- PRISMA guidelines were followed to select 109 studies published between 2010 and 2024.
Main Results:
- A significant shift towards interdisciplinary collaboration was observed, with 68% of studies focusing on general multidisciplinary aspects.
- Computer-Aided Drug Design (CADD) comprised 10% of research, and educational leadership 22%.
- Identified challenges include resource limitations, policy gaps, and communication barriers; educational leadership was often missing in CADD and network pharmacology frameworks.
Conclusions:
- Strengthening educational leadership is crucial for sustainable capacity building in pharmaceutical sciences.
- Institutional frameworks, regulatory support, and adaptive leadership are necessary for knowledge sharing and innovation.
- Enhanced educational leadership can lead to long-term positive effects and improved research outcomes in multidisciplinary pharmaceutical research.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...